The central government has soft-launched “Nafithromycin”. It is India’s first indigenously developed antibiotic, to treat patients with bacterial infections that lead to death when pathogens no longer respond to existing antibiotics. The drug, developed by Maharashtra-based Wockhardt Ltd., works against multidrug-resistant isolates. Drug-resistant pneumonia is a condition responsible for over two million deaths globally each […]